DrugPatentWatch Database Preview
Zydus Pharms Usa Company Profile
What is the competitive landscape for ZYDUS PHARMS USA, and when can generic versions of ZYDUS PHARMS USA drugs launch?
ZYDUS PHARMS USA has one hundred and ninety-two approved drugs.
There is one US patent protecting ZYDUS PHARMS USA drugs. There are nine tentative approvals on ZYDUS PHARMS USA drugs.
There are two patent family members on ZYDUS PHARMS USA drugs in two countries and two hundred and forty-one supplementary protection certificates in thirteen countries.
Summary for Zydus Pharms Usa
| International Patents: | 2 |
| US Patents: | 1 |
| Tradenames: | 159 |
| Ingredients: | 158 |
| NDAs: | 192 |
Drugs and US Patents for Zydus Pharms Usa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Pharms Usa Inc | ETODOLAC | etodolac | TABLET, EXTENDED RELEASE;ORAL | 091134-003 | Jan 23, 2014 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Zydus Pharms Usa Inc | TOPIRAMATE | topiramate | TABLET;ORAL | 078235-002 | Mar 27, 2009 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Zydus Pharms Usa Inc | CARVEDILOL | carvedilol | TABLET;ORAL | 077614-001 | Sep 5, 2007 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Zydus Pharms Usa Inc | VARDENAFIL HYDROCHLORIDE | vardenafil hydrochloride | TABLET;ORAL | 208960-004 | Oct 31, 2018 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Zydus Pharms Usa Inc | DOXAZOSIN MESYLATE | doxazosin mesylate | TABLET;ORAL | 208719-004 | Jul 7, 2017 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Zydus Pharms Usa Inc | BROMOCRIPTINE MESYLATE | bromocriptine mesylate | CAPSULE;ORAL | 078899-001 | Jul 30, 2008 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Zydus Pharms Usa Inc | ALLOPURINOL | allopurinol | TABLET;ORAL | 210117-002 | Oct 12, 2017 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ZYDUS PHARMS USA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
International Patents for Zydus Pharms Usa Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2011089623 | ➤ Sign Up |
| Japan | 2013516459 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Zydus Pharms Usa Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2012 00035 | Denmark | ➤ Sign Up | PRODUCT NAME: ET KOMBINATIONSPRODUKT AF NAPROXEN OG ESOMEPRAZOL MAGNESIUM TRIHYDRAT; NAT. REG. NO/DATE: 49583 20120327; FIRST REG. NO/DATE: GB PL 17901/0263-001 20101105 |
| 00172 | Netherlands | ➤ Sign Up | PRODUCT NAME: EZETIMIBE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, EN SIMVASTATINE; NAT. REGISTRATION NO/DATE: RVG 30927RVG 30928RVG 30929RVG 30930 2004221122; FIRST REGISTRATION: 58874.00.0058874.01.0058874.02.0058874.03.0058878.00.0058878.01.0058878.02.0058878.03.0058866.00.0058866.01.0058866.02.0058866.03.0058870.00.0058870.01.0058870.02.0058870.03.00 2004020402 |
| C/GB97/023 | United Kingdom | ➤ Sign Up | PRODUCT NAME: DONEPEZIL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, INCLUDING THE HYDROCHLORIDE; REGISTERED: UK PL 10555/0006 19970214; UK PL 10555/0007 19970214 |
| C0036 | Belgium | ➤ Sign Up | PRODUCT NAME: CLOPIDOGREL HYDROGENE SULFATE; REGISTRATION NO/DATE IN FRANCE: EU/1/98 /069/001 DU 19980715; REGISTRATION NO/DATE AT EEC: DU EU/1-/98/069/001 |
| C/GB02/033 | United Kingdom | ➤ Sign Up | PRODUCT NAME: FORMOTEROL (OPTIONALLY IN THE FORM OF THE FREE BASE OR A PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF, OR A SOLVATE OF SUCH FREE BASE OR SALT ESPECIALLY AS FORMOTEROL FUMARATE DIHYDRATE) AND BUDESONIDE; REGISTERED: SE SE16047, 16048 20000825; UK PL17901/0091 20010515; UK PL17901/0092 20010515 |
| 00677 | Netherlands | ➤ Sign Up | PRODUCT NAME: COMBINATIE VAN DAPAGLIFLOZINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN EN METFORMINE OF EEN FARMACEITISCH AANVAARDBAAR ZOUT DAARVAN, ZOALS BESCHERMD DOOR HET BASISOCTROOI EP 1506211B1; REGISTRATION NO/DATE: EU/1/13/900 20140121 |
| C0006 | France | ➤ Sign Up | PRODUCT NAME: PIOGLITAZONE/METFORMINE ET LEURS SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE IN FRANCE: EU/1/06/354/001 DU 20060728; REGISTRATION NO/DATE AT EEC: EU/1/06/354/001 DU 20060728 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
